A Single Center, Prospective Clinical Trial of Intravenous Ertapenem in the Treatment of Hurley Stage II or III Hidradenitis Suppurativa
NCT05255575
·
clinicaltrials.gov ↗
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
unavailable staff to support project
Conditions
Hidradenitis Suppurativa
Interventions
DRUG:
Ertapenem
Sponsor
Henry Ford Health System